Analystreport

Pluristem Therapeutics Inc. (NASDAQ: PSTI) was given a new $4.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

Pluristem Therapeutics, Inc.  (PSTI) 
Last pluristem therapeutics, inc. earnings: 2/6 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: pluristem.com